As the Director of Strategy and Innovation at GHV, Rahima leads the Global Health Innovations Portfolio, along with our private sector and partner-facing DEI work. She has supported partners including the Bill and Melinda Gates Foundation and Eli Lilly. Within her portfolio, Rahima brings 15 years of deep expertise in strategic planning, market access, infectious diseases, pandemic preparedness, global health innovation, market shaping, innovative finance, and product introduction and uptake.

An experienced consultant, Rahima has also worked extensively across the public, private, and nonprofit sectors across healthcare, social impact, and DEI.

Previously, Rahima served as a senior market access advisor at USAID’s Center for Innovation and Impact in the Global Health Bureau. She also worked with the Clinton Health Access Initiative (CHAI), where she partnered with Malawi’s Ministry of Health to help introduce the rotavirus vaccine and strengthen the vaccine delivery system and in Myanmar to improve market intelligence around TB diagnostics and improve the testing system for identification of MDR-TB.

Rahima holds an MBA from the Harvard Business School and an MPH in global health from the Harvard School of Public Health. She also holds a B.A., summa cum laude, from the University of Pennsylvania in global health and healthcare management. She has lived and worked in Malawi, Myanmar, India, and Pakistan. She currently resides in Toronto, Canada.

Outside of work, Rahima is a yoga instructor, a career coach, and a private chef. She enjoys landscape photography, pottery, and painting very poorly.

‍

Areas of Expertise:

• Global health innovation, market access, supply chain, product introduction

• Infectious diseases, diagnostics, pandemic preparedness

• Diversity, equity, and inclusion

• Strategy and strategic planning

• Private sector (social impact and global health)